Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gynesonics Inc.

This article was originally published in Start Up

Executive Summary

Gynesonics wants to help gynecologists recapture revenues that are now being lost through referrals to interventional radiologists. Its minimally invasive VizAblate system combines diagnostic ultrasound imaging and RF delivery in a single devivce to ablate uterine fibroids.

You may also be interested in...



Women's Health: Building Interventional Gynecology

This article was adapted from "Building Interventional Gynecology," which appeared in START-UP, June 2010.

Women's Health: Building Interventional Gynecology

This article was adapted from "Building Interventional Gynecology," which appeared in START-UP, June 2010.

Building Interventional Gynecology

Once a sluggish category for clinical innovation, gynecology is drawing new venture-backed companies eager to build upon the lead created by first-generation companies operating in minimally-invasive endometrial ablation and female sterilization. First generation companies had the difficult task of creating paths to early adopters of minimally invasive procedures. These now exist, and the clinical specialty appears to be also evolving in ways that encourage the growth of in-office procedures.

Related Content

Related Companies

Latest News
UsernamePublicRestriction

Register

SC091310

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel